Journal-Based CME: The PML hub: An emerging actor of leukemia therapies

Journal-Based CME: The PML hub: An emerging actor of leukemia therapies is organized by Memorial Sloan Kettering Cancer Center (MSKCC).

Release Date: 29-06-2023
Expired Date: 29-06-2026

Description:
This Journal-Based CME activity consists of a full-text article that is free to read, a multiple-choice question test, and an evaluation/self-assessment. Learners are tested on their comprehension of the key concepts, with the objective of enriching their clinical practice and patient care through better understanding of scientific advances and new techniques in the fields covered by Journal of Experimental Medicine (JEM).

Questions for this complimentary, online-only activity have been designed by JEM editors in collaboration with the article authors. Each CME activity should take approximately 1 hour to complete.

The article selected for this activity is “The PML hub: An emerging actor of leukemia therapies,” by Domitille Rérolle and Hugues de Thé of the Center for Interdisciplinary Research in Biology, Collège de France, Inserm, PSL Research University in Paris, France.

Additional details will be posted as soon as information is available.